Events and Activities

Join colleagues in-person in Boston, MA and Virtually from anywhere in the world.

Expo Hall Schedule

Visit the Expo Hall to explore groundbreaking innovations and network with industry leaders.

 Monday, 2 JunTuesday, 3 Jun
Expo Hall Open1030 – 19001000 - 1345
Networking Continental Breakfast 0730 – 0830
Networking Break in the Expo Hall
  • 1030 – 1115
  • 1530 – 1615
1000 – 1045
Networking Lunch in the Expo Hall1245 – 14001215 – 1345
Welcome Reception in the Expo Hall1730 – 1900 

 

Monday, 2 June 2025

Welcome Reception in the Expo Hall

 1730 – 1900 | Included with In-Person All Access Pass

Connect with industry leaders at our Welcome Reception. Enjoy food and beverages in the Expo Hall while networking with exhibitors and attendees.

Facility Tours

Wednesday, 4 June 2025

ElevateBio

ben gebo photography - richmond_group_elevate_bio

0900 - 1300 | US$75 | Separate registration is required.

ElevateBioParticipants will view a brief presentation on ElevateBio and then tour the BaseCamp Waltham facility with members of the leadership team. Refreshments and Q&A to follow.

ElevateBio is a technology-driven company powering the creation of life-transforming genetic medicines, combining manufacturing capabilities and R&D technologies, to accelerate the discovery and development of advanced therapeutics.

BaseCamp® is ElevateBio’s genetic medicine current Good Manufacturing Practice (cGMP) manufacturing and process development business enabling biopharmaceutical partners with end-to-end capabilities. ElevateBio’s 140,000 sq. ft. flagship BaseCamp facility in Waltham, Massachusetts provides the tools, expertise, and resources necessary to bring these advanced therapies from concept to commercialization. The facility features Grade B and C BSL2 cleanrooms, three viral vector suits for lentiviral, AAV, and mRNA production, and six dedicated cell therapy suites. Through BaseCamp, ElevateBio supports a growing number of partners across a wide breadth of modalities, including lentiviral gene therapies, AAV gene therapies, TCR-T and CAR-T cell therapies, engineered B cells, mRNA vaccines, and more.

Wednesday, 4 June 2025

Takeda

Takeda's Massachusetts Biologics Operations

0900 - 1300 | US$75 | Separate registration is required.

Welcome to the Lexington site of Takeda's Massachusetts Biologics Operations. Our mission here is to deliver innovative medicines that provide life-changing treatments for our patients. We focus on achieving commercial supply excellence and pioneering new therapies through innovation, people, and performance. The Lexington site supports approximately $846 million in revenue through the production of drug substances such as Replagal, VPRIV, and Takhzyro, which serve patients with various rare and genetic disorders.

Manufacturing Capabilities:

  • Multiproduct Biologics: We specialize in both clinical and commercial drug substance (DS) manufacturing.
  • Quality Control (QC) Testing: Ensuring the highest standards of product consistency, quality, and purity.
  • Cell Bank Manufacturing and Testing: We manage the production and testing of cell banks, crucial for biologics manufacturing.
  • Cell Therapy Manufacturing: The site is equipped to support innovative cell therapy manufacturing processes.